Related Experiment Video
Updated: Dec 19, 2025
08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
18.6K
Dendritic Cells and Their Role in Immunotherapy
Alycia Gardner1,2, Álvaro de Mingo Pulido1, Brian Ruffell1,3
1Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.
Frontiers in Immunology
|June 9, 2020
Summary
Dendritic cells are key to cancer immunotherapy, but current treatments are limited. New strategies focus on enhancing dendritic cell function within tumors to improve treatment efficacy for more patients.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Cancer immunotherapy has advanced, yet many patients lack treatment benefits.
- Dendritic cells are crucial for adaptive immunity and have been a focus for cancer vaccines with limited success.
- Emerging strategies include immune checkpoint blockade and neoantigen identification.
Purpose of the Study:
- To review the role of dendritic cell subsets in anti-tumor immunity.
- To discuss the current status of dendritic cell-based immunotherapies.
- To identify future research and clinical trial directions.
Main Methods:
- Review of existing literature on dendritic cell subsets and anti-tumor immune responses.
- Analysis of current clinical trials involving dendritic cell-based immunotherapies.
- Discussion of emerging therapeutic strategies and their potential.
Main Results:
- Dendritic cells are critical regulators of the immune response within tumors.
- Augmenting intratumoral dendritic cell function may enhance immunotherapy efficacy.
- Dendritic cells play a role in improving cytotoxic and targeted therapies.
Conclusions:
- Dendritic cell subsets differentially regulate anti-tumor immune responses.
- Enhancing intratumoral dendritic cell function presents a promising avenue for cancer treatment.
- Further research and clinical trials are needed to optimize dendritic cell-based immunotherapies.
Related Concept Videos
01:27Tumor Immunotherapy
1.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K
01:22T Cell Activation and Clonal Selection
14.3K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.3K
01:27Cytotoxic T Cells-mediated Immune Response
6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
01:30Cancer Vaccines
867
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
867
01:24T Cell Types and Functions
2.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.0K
01:22Antigen Presenting Cells
2.8K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
2.8K